Skip to main content

Recombinant Mouse alpha-L-Iduronidase/IDUA Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 9348-GH

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
9348-GH-010

Key Product Details

Source

NS0

Accession #

Conjugate

Unconjugated

Applications

Enzyme Activity

Product Specifications

Source

Mouse myeloma cell line, NS0-derived mouse alpha-L-Iduronidase/IDUA protein
Glu17-Ser634, with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Glu17

Predicted Molecular Mass

70 kDa

SDS-PAGE

83-95 kDa, reducing conditions

Activity

Measured by its ability to cleave a fluorogenic substrate, 4-Methylumbelliferyl alpha-L-iduronide.
 The specific activity is >7,500 pmol/min/ug, as measured under the described conditions.

Formulation, Preparation and Storage

9348-GH
Formulation Supplied as a 0.2 μm filtered solution in Sodium Acetate, NaCl and Glycerol.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: alpha-L-Iduronidase/IDUA

alpha-L-Iduronidase encoded by the IDUA gene is an important enzyme required for the lysosomal degradation of glycosaminoglycans (GAGS). It hydrolyzes the
non-reducing terminal alpha-L-iduronic acid residues in GAGS including dermatan sulfate and heparan sulfate.  Mature mouse IDUA shares 80% aa identity with human IDUA. Mutations in IDUA that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I) (1). MPS I can be classified as three clinical subtypes; Hurler syndrome, Hurler-Scheie syndrome, and Scheie syndrome with decreasing severity, respectively. MPS I causes progressive cellular, tissue and organ damage, and several clinical studies using enzyme replacement therapy show positive results (2, 3). Recently, the IDUA gene has been linked to osteoporosis (4, 5).

References

  1. Scott, H.S. et al. (1995) Hum. Mutat. 6:288.
  2. Wraith, J.E. (2005) Expert Opin. Pharmacother. 6:489.
  3. Jameson, E. (2016) Cochrane Database Syst. Rev. 4: CD009354.
  4. Kodric, K. et al. (2016) Wien Klin Wochenschr. 128:480.
  5. Niu, T. et al. (2016) J. Bone Miner. Res. 31:358.

Alternate Names

alphaLIduronidase, IDA, IDUA

Entrez Gene IDs

3425 (Human); 15932 (Mouse); 360904 (Rat); 102116889 (Cynomolgus Monkey)

Gene Symbol

IDUA

UniProt

Additional alpha-L-Iduronidase/IDUA Products

Product Documents for Recombinant Mouse alpha-L-Iduronidase/IDUA Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Mouse alpha-L-Iduronidase/IDUA Protein, CF

For research use only

Loading...
Loading...
Loading...